LONDON A study of one million people has found that physical inactivity costs the global economy $67.5 billion a year in healthcare and productivity losses, but an hour a day of exercise could eliminate most of that.
Jim Ratigan, who left his post at Deutsche Bank AG as head of Americas mergers and acquisitions earlier this month, has agreed to join U.S. healthcare investment banking boutique Leerink Partners LLC, a Leerink spokesman said on Monday.
NEW YORK With U.S. healthcare shares looking cheap and business and demographic trends supporting the industry's outlook, some investors are betting the sector will resume beating the broader market it has out-gained for much of the decade.
U.S. seed company Monsanto Co turned down a sweetened $64 billion acquisition offer from Bayer AG , but said it was open to further talks with the German healthcare and chemicals group as well as other parties.
UnitedHealth Group Inc is still losing money on the individual insurance business created under U.S. President Barack Obama's national healthcare reform law due to customers' high medical costs, the company said on Tuesday.
Healthcare spending in the United States will likely grow by an average 5.8 percent per year over the next decade, a bit faster than the past two years, due to an aging population, rising medical prices and faster economic growth, according to updated projections from the federal government released on Wednesday.
LONDON General Electric's healthcare unit aims to build a $1 billion business offering vital manufacturing tools for a coming wave of cell therapies, helped by the acquisition of a Swiss firm that doubles its presence in the field.
President Barack Obama on Monday urged Congress to reconsider offering a government-run health insurance option alongside private plans on the exchanges created as part of his national healthcare law.
SHANGHAI/LONDON As China's medical bills rise steeply, outpacing government insurance provision, patients and their families are increasingly turning to loans to pay for healthcare, adding to the country's growing burden of consumer debt.
LONDON Japan's Eisai said on Friday it would consider all options, including possible legal action, to fight delays in Britain's healthcare system that prevent patients from accessing one of its drugs to treat a rare form of cancer.
Prosecutors demanded details from Valeant Pharmaceuticals on its patient assistance programs, drug pricing and distribution practices. Full Article